Physician profile
Mary E Cole
NPI 1518377522
$1,961.68
in general payments reported to CMS, 2019-2025
13 companies · $728 in 2025
The $728 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.34 · 2022: $55.47 · 2023: $288 · 2024: $843 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,858.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $555.43 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Axsome Therapeutics, INC. | $431.41 | 2023-2025 | Auvelity |
| Lilly USA, LLC | $309.83 | 2024-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $223.05 | 2021-2025 | |
| Idorsia Pharmaceuticals US INC | $107.10 | 2023 | Quviviq |
| Exact Sciences Corporation | $94.07 | 2023-2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $93.87 | 2022-2025 | |
| Corcept Therapeutics | $35.37 | 2025 | Korlym |
| Astellas Pharma US INC | $34.89 | 2025 | Veozah |
| Inspire Medical Systems, INC. | $28.13 | 2025 | Inspire |
| Ethicon US, LLC | $24.86 | 2024 | Evarrest |
| Otsuka America Pharmaceutical, INC. | $16.88 | 2024 | Rexulti |
| Phathom Pharmaceuticals, INC. | $6.79 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.